Clinical Efficacy and Safety of Compound Methyl Salicylate Liniment
CompletedNot applicableNCT03362216
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This clinical trial program was established according to the ethical principles of the Helsinki declaration and the GCP guiding principle, and a randomized grouping method was used to evaluate the efficacy and safety of Compound Methyl Salicylate Liniment in the treatment of acute and chronic soft tissue pain with a positive control drug, named Diclofenac Sodium Liniment.
Study details
- Official title
- Clinical Efficacy and Safety of Compound Methyl Salicylate Liniment in the Treatment of Acute and Chronic Soft Tissue Pain：a Multicenter, Randomized, Positive Controlled Clinical Trial
- Conditions
- Soft Tissue Injuries
- Interventions
- Drug: Compound Methyl Salicylate Liniment
- Drug: Diclofenac Sodium Liniment
- Sponsor
- Peking University People's Hospital
- Start date
- 2009-04-07
- Primary completion
- 2009-05-22
- Sex
- All
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with various causes of acute and chronic soft tissue * Local symptoms and signs include pain, swelling, bruising, tenderness, joint dysfunction; X-ray showed no fracture, dislocation, bone tumors and bone metabolism and open injury. Exclusion Criteria: * Patients who do not belong to the scope of drug use * Muscle, tendon, ligament and other soft tissue have broken completely * Accompanied by skin damage or fracture, joint dislocation, bone tumor and metabolic bone disease local tissue damage * Use of other drugs or therapies for the treatment of acute and chronic soft tissue pain after trauma * Difficult to evaluate the effectiveness and safety of new drugs * Severe hypertension, severe heart and lung dysfunction, severe arrhythmia, liver, kidney, hematopoietic system and other serious primary diseases, mental patients * Pregnant women, lactating women * Allergic constitution and allergic to the known components of the drug * Participated in other clinical trials in the past month * Use similar analgesics within a week * Other researchers considered inappropriate patients to participate in the trial
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03362216